AI assistant
NextTrip, Inc. — Director's Dealing 2019
Jul 23, 2019
34837_dirs_2019-07-22_c1f919fe-38c6-4c5c-961f-0b7c569b8b48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGMA LABS, INC. (SGLB)
CIK: 0000788611
Period of Report: 2019-07-18
Reporting Person: Orzechowski Frank (CFO, PFO and PAO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-18 | Stock Option (right to buy) | $1.4 | A | 2500 | Acquired | 2024-06-30 | Common Stock (2500) | Direct |
| 2019-07-18 | Stock Option (right to buy) | $1.4 | A | 60000 | Acquired | 2024-06-30 | Common Stock (60000) | Direct |
Footnotes
F1: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019.
F2: The stock option vests as follows: 3,872 shares will vest and become exercisable on July 1, 2020; 9,000 shares will vest and become exercisable on July 1, 2021; 14,128 shares will vest and become exercisable on July 1, 2022, and 33,000 shares will vest and become exercisable on July 1, 2023, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.